Guest guest Posted March 30, 2007 Report Share Posted March 30, 2007 BlankProstate-Cancer Treatment Is Endorsed by FDA Panel A Food and Drug Administration panel of outside medical experts backed an experimental prostate-cancer treatment designed to stimulate a person's immune system to fight the cancer, despite concerns it might not be that effective. The panel unanimously said the first-of-a-kind treatment, Provenge, by Dendreon Corp., of Seattle, was safe. It also said the FDA should consider approving Provenge despite two clinical studies showing it didn't meet study goals. The Provenge studies showed the treatment failed to meet a goal of reducing so-called time to progression, or the advancement, of cancer. However, a subsequent analysis of one of the studies, which involved 127 men, showed those receiving Provenge lived about 4.5 months longer than men not receiving the treatment. Most panel members said that survival data suggests that the treatment might work. Provenge is considered a therapeutic vaccine that is made using a patient's own white blood cells -- combining them with a protein and infusing this back into a person. Existing therapies are aimed at killing cancer cells or choking off blood supply and other proteins involved in cancer growth. Full story http://online.wsj.com/article/SB117517805142353190.html?mod=health_home_stories Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.